References
- 1Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, et al. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord Off J Mov Disord Soc. 2018; 33(1): 75–87. DOI: 10.1002/mds.27121
- 2Magrinelli F, Latorre A, Balint B, Mackenzie M, Mulroy E, Stamelou M, et al. Isolated and combined genetic tremor syndromes: a critical appraisal based on the 2018 MDS criteria. Parkinsonism Relat Disord. agosto. 2020; 77: 121–40. DOI: 10.1016/j.parkreldis.2020.04.010
- 3Hopfner F, Helmich RC. The etiology of essential tremor: Genes versus environment. Parkinsonism Relat Disord. gennaio. 2018; 46(Suppl 1): S92–6. DOI: 10.1016/j.parkreldis.2017.07.014
- 4Yeow D, Rudaks LI, Siow SF, Davis RL, Kumar KR. Genetic Testing of Movements Disorders: A Review of Clinical Utility. Tremor Hyperkinetic Mov N Y N. 2024; 14(2):. DOI: 10.5334/tohm.835
- 5Diez-Fairen M, Bandres-Ciga S, Houle G, Nalls MA, Girard SL, Dion PA, et al. Genome-wide estimates of heritability and genetic correlations in essential tremor. Parkinsonism Relat Disord. luglio. 2019; 64: 262–7. DOI: 10.1016/j.parkreldis.2019.05.002
- 6Bologna M, Espay AJ, Fasano A, Paparella G, Hallett M, Berardelli A. Redefining Bradykinesia. Mov Disord Off J Mov Disord Soc. 27 febbraio 2023. DOI: 10.1002/mds.29362
- 7Bologna M, Paparella G, Fasano A, Hallett M, Berardelli A. Evolving concepts on bradykinesia. Brain J Neurol. 1 marzo. 2020; 143(3): 727–50. DOI: 10.1093/brain/awz344
- 8Paparella G, Fasano A, Hallett M, Berardelli A, Bologna M. Emerging concepts on bradykinesia in non-parkinsonian conditions. Eur J Neurol. 1 aprile 2021. DOI: 10.1111/ene.14851
- 9Angelini L, Paparella G, De Biase A, Maraone A, Panfili M, Berardelli I, et al. Longitudinal study of clinical and neurophysiological features in essential tremor. Eur J Neurol. 27 novembre 2022. DOI: 10.1111/ene.15650
- 10Paparella G, Cannavacciuolo A, Angelini L, Costa D, Birreci D, Alunni Fegatelli D, et al. May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals? J Park Dis. 2023; 13(6): 1049–62. DOI: 10.3233/JPD-230119
- 11Bologna M, Berardelli I, Paparella G, Ferrazzano G, Angelini L, Giustini P, et al. Tremor Distribution and the Variable Clinical Presentation of Essential Tremor. Cerebellum Lond Engl. ottobre. 2019; 18(5): 866–72. DOI: 10.1007/s12311-019-01070-0
- 12Paparella G, Angelini L, De Biase A, Cannavacciuolo A, Colella D, Di Bonaventura C, et al. Clinical and Kinematic Features of Valproate-Induced Tremor and Differences with Essential Tremor. Cerebellum Lond Engl. 16 novembre 2020. DOI: 10.1007/s12311-020-01216-5
- 13Angelini L, Terranova R, Lazzeri G, van den Berg KRE, Dirkx MF, Paparella G. The role of laboratory investigations in the classification of tremors. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. dicembre 2023; 44(12): 4183–92. DOI: 10.1007/s10072-023-07108-w
- 14Deuschl G, Becktepe JS, Dirkx M, Haubenberger D, Hassan A, Helmich RC, et al. The clinical and electrophysiological investigation of tremor. Clin Neurophysiol Off J Int Fed Clin Neurophysiol. aprile 2022; 136: 93–129. DOI: 10.1016/j.clinph.2022.01.004
- 15Liu HF, Yuan TY, Yang JW, Li F, Wang F, Fu HM. A novel de novo heterozygous variant of the KCNQ2 gene: Contribution to early-onset epileptic encephalopathy in a female infant. Mol Med Rep. settembre 2022; 26(3): 282. DOI: 10.3892/mmr.2022.12797
- 16Goto A, Ishii A, Shibata M, Ihara Y, Cooper EC, Hirose S. Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy. Epilepsia. settembre 2019; 60(9): 1870–80. DOI: 10.1111/epi.16314
- 17Al Yazidi G, Shevell MI, Srour M. Two Novel KCNQ2 Mutations in 2 Families With Benign Familial Neonatal Convulsions. Child Neurol Open. 2017;4:2329048X17691396. DOI: 10.1177/2329048X17691396
- 18Schmidt A, Röner S, Mai K, Klinkhammer H, Kircher M, Ludwig KU. Predicting the pathogenicity of missense variants using features derived from AlphaFold2. Bioinforma Oxf Engl. 4 maggio 2023; 39(5): btad280. DOI: 10.1093/bioinformatics/btad280
- 19Niroula A, Vihinen M. How good are pathogenicity predictors in detecting benign variants? PLoS Comput Biol. febbraio 2019; 15(2):
e1006481 . DOI: 10.1371/journal.pcbi.1006481 - 20Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med Off J Am Coll Med Genet. maggio 2015; 17(5): 405–24. DOI: 10.1038/gim.2015.30
- 21Fritch PC, McNaughton-Smith G, Amato GS, Burns JF, Eargle CW, Roeloffs R, et al. Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain. J Med Chem. 28 gennaio 2010; 53(2): 887–96. DOI: 10.1021/jm901497b
- 22Ślęczkowska M, Misra K, Santoro S, Gerrits MM, Hoeijmakers JGJ, PainNet Study Group. Ion Channel Genes in Painful Neuropathies. Biomedicines. 29 settembre 2023; 11(10): 2680. DOI: 10.3390/biomedicines11102680
- 23Bennett DLH, Woods CG. Painful and painless channelopathies. Lancet Neurol. giugno 2014; 13(6): 587–99. DOI: 10.1016/S1474-4422(14)70024-9
- 24d’Apolito M, Ceccarini C, Savino R, Adipietro I, di Bari I, Santacroce R, et al. A Novel KCNN2 Variant in a Family with Essential Tremor Plus: Clinical Characteristics and In Silico Analysis. Genes. 29 giugno 2023; 14(7): 1380. DOI: 10.3390/genes14071380